These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16218486)

  • 1. Bisphosphonates and atherosclerosis: why?
    Bevilacqua M; Dominguez LJ; Rosini S; Barbagallo M
    Lupus; 2005; 14(9):773-9. PubMed ID: 16218486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates and atherosclerosis.
    Ylitalo R
    Gen Pharmacol; 2000 Dec; 35(6):287-96. PubMed ID: 11922958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates: the first 40 years.
    Russell RG
    Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonates: from the laboratory to the clinic and back again.
    Russell RG; Rogers MJ
    Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bisphosphonates for vascular calcification].
    Tanaka Y; Okada Y
    Clin Calcium; 2007 Mar; 17(3):386-90. PubMed ID: 17339743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Fitton A; McTavish D
    Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.
    Roelofs AJ; Thompson K; Ebetino FH; Rogers MJ; Coxon FP
    Curr Pharm Des; 2010; 16(27):2950-60. PubMed ID: 20722616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New bisphosphonates in osteoporosis.
    Fleisch H
    Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of action of the bisphosphonates.
    Fleisch H
    Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.
    Rogers MJ
    Calcif Tissue Int; 2004 Dec; 75(6):451-61. PubMed ID: 15332174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease.
    Fleisch H
    Drugs; 1991 Dec; 42(6):919-44. PubMed ID: 1724640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro.
    Ylitalo R; Kalliovalkama J; Wu X; Kankaanranta H; Salenius JP; Sisto T; Lähteenmäki T; Ylitalo P; Pörsti I
    Pharmacol Toxicol; 1998 Sep; 83(3):125-31. PubMed ID: 9783331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
    Fleisch H
    Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: A clue to the mechanism of action of nitrogen-containing bisphosphonates.
    van beek E; Löwik C; van der Pluijm G; Papapoulos S
    J Bone Miner Res; 1999 May; 14(5):722-9. PubMed ID: 10320520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of bisphosphonates.
    Reszka AA; Rodan GA
    Curr Osteoporos Rep; 2003 Sep; 1(2):45-52. PubMed ID: 16036064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of liposome-encapsulated bisphosphonates on acetylated LDL metabolism, lipid accumulation and viability of phagocyting cells.
    Ylitalo R; Mönkkönen J; Ylä-Herttuala S
    Life Sci; 1998; 62(5):413-22. PubMed ID: 9449231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).
    Timchenko TP
    Sovrem Tekhnologii Med; 2022; 14(2):68-78. PubMed ID: 37065429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the use of clodronate in osteoporosis.
    Kanis JA; McCloskey EV; Sirtori P; Khan S; Fern D; Eyres K; Aaron J; Beneton MN
    Osteoporos Int; 1993; 3 Suppl 2():S23-8. PubMed ID: 8481595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.